Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carozzi

Showing results (341-350 of 413) with videos related to

Pageof 42
Sort By:
International Journal of Cancer|March 15, 2020
Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screeningJack Cuzick, Rachael Adcock, Francesca Carozzi, et al.
Lung Cancer (Amsterdam, Netherlands)|October 27, 2019
Decreased cardiovascular mortality in the ITALUNG lung cancer screening trial: Analysis of underlying factorsDonella Puliti, Mario Mascalchi, Francesca Maria Carozzi, et al.
International Journal of Cancer|February 18, 2018
Human papilloma virus genotyping for the cross-sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or moreAnnarosa Del Mistro, Rachael Adcock, Francesca Carozzi, et al.
Cancer|June 18, 2003
A feasibility study of the use of the AutoPap screening system as a primary screening and location-guided rescreening deviceMassimo Confortini, Lucia Bonardi, Paolo Bulgaresi, et al.
Plos One|May 18, 2021
Pool testing on random and natural clusters of individuals: Optimisation of SARS-CoV-2 surveillance in the presence of low viral load samplesMichela Baccini, Emilia Rocco, Irene Paganini, et al.
Cancer Communications (London, England)|February 26, 2026
Effectiveness of Lung Cancer Screening by Sex and Tumor Histology: Extended, Pooled Analysis of the ITALUNG and LUSI Trials, with Comparison to Findings in the NLSTRudolf Kaaks, Francisco Omar Cortés-Ibáñez, Stefan Delorme, et al.
Cell Cycle (Georgetown, Tex.)|December 17, 2013
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathyCristina Meregalli, Alessia Chiorazzi, Valentina A Carozzi, et al.
Frontiers in Pharmacology|June 4, 2019
Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic CancerAnna Tesei, Michela Cortesi, Sara Pignatta, et al.
Diagnostic Cytopathology|June 27, 2003
Clinical impact (cost-effectiveness) of qualifying atypical squamous cells of undeterminate significance (ASCUS) in cases favoring a reactive or dysplastic processF M Carozzi, M P Cariaggi, L Bonardi, et al.
Cancers|June 27, 2024
Baseline Cell-Free DNA Can Predict Malignancy of Nodules Observed in the ITALUNG Screening TrialSimonetta Bisanzi, Donella Puliti, Giulia Picozzi, et al.
Pageof 42

Showing results (341-350 of 413) with videos related to

Sort By:
Pageof 42
International Journal of Cancer|March 15, 2020
Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screeningJack Cuzick, Rachael Adcock, Francesca Carozzi, et al.
Lung Cancer (Amsterdam, Netherlands)|October 27, 2019
Decreased cardiovascular mortality in the ITALUNG lung cancer screening trial: Analysis of underlying factorsDonella Puliti, Mario Mascalchi, Francesca Maria Carozzi, et al.
International Journal of Cancer|February 18, 2018
Human papilloma virus genotyping for the cross-sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or moreAnnarosa Del Mistro, Rachael Adcock, Francesca Carozzi, et al.
Cancer|June 18, 2003
A feasibility study of the use of the AutoPap screening system as a primary screening and location-guided rescreening deviceMassimo Confortini, Lucia Bonardi, Paolo Bulgaresi, et al.
Plos One|May 18, 2021
Pool testing on random and natural clusters of individuals: Optimisation of SARS-CoV-2 surveillance in the presence of low viral load samplesMichela Baccini, Emilia Rocco, Irene Paganini, et al.
Cancer Communications (London, England)|February 26, 2026
Effectiveness of Lung Cancer Screening by Sex and Tumor Histology: Extended, Pooled Analysis of the ITALUNG and LUSI Trials, with Comparison to Findings in the NLSTRudolf Kaaks, Francisco Omar Cortés-Ibáñez, Stefan Delorme, et al.
Cell Cycle (Georgetown, Tex.)|December 17, 2013
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathyCristina Meregalli, Alessia Chiorazzi, Valentina A Carozzi, et al.
Frontiers in Pharmacology|June 4, 2019
Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic CancerAnna Tesei, Michela Cortesi, Sara Pignatta, et al.
Diagnostic Cytopathology|June 27, 2003
Clinical impact (cost-effectiveness) of qualifying atypical squamous cells of undeterminate significance (ASCUS) in cases favoring a reactive or dysplastic processF M Carozzi, M P Cariaggi, L Bonardi, et al.
Cancers|June 27, 2024
Baseline Cell-Free DNA Can Predict Malignancy of Nodules Observed in the ITALUNG Screening TrialSimonetta Bisanzi, Donella Puliti, Giulia Picozzi, et al.
Pageof 42